Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Alzheimers Dement. 2022 Feb 25;18(12):2603–2613. doi: 10.1002/alz.12640

Table 3.

Participant characteristics at time of enrollment by ethnocultural groups

Total
N=2,286
n (%)
Latinx
N=88
n (%)
Non-
Latinx
Asian
N=46
n (%)
Non-
Latinx
Black
N=114
n (%)
Non-
Latinx
White
N=2,003
n (%)
Others
N=35
n (%)
p
Age in years * 73.21 (7.22) 70.23 (7.51) 73.93 (8.06) 71.45 (7.37) 73.46 (7.13) 71.13 (7.40) <.001
Sex at birth <.001
  Male 1214 (53%) 36 (41%) 24 (52%) 41 (36%) 1101 (55%) 12 (34%)
  Female 1072 (47%) 52 (59%) 22 (48%) 73 (64%) 902 (45%) 23 (66%)
Education * 16.05 (2.76) 15.25 (3.25) 17.26 (2.14) 15.17 (2.94) 16.09 (2.72) 16.51 (2.80) <.001
Education attainment group .013
  ≤12 years 339 (15%) 17 (19%) 1 (2%) 24 (21%) 292 (15%) 5 (14%)
  >12 years 1947 (85%) 71 (81%) 45 (98%) 90 (79%) 1711 (85%) 30 (86%)
Diagnosis group .033
  Cognitively unimpaired 831 (36%) 35 (40%) 19 (41%) 58 (51%) 707 (35%) 12 (34%)
  Mild cognitive impairment 1056 (46%) 39 (44%) 17 (37%) 39 (34%) 944 (47%) 17 (49%)
  Alzheimer’s disease 399 (17%) 14 (16%) 10 (22%) 17 (15%) 352 (18%) 6 (17%)
Family history of AD/dementia .427
  No 833 (41%) 27 (36%) 17 (42%) 44 (48%) 731 (41%) 14 (45%)
  Yes 1198 (59%) 49 (64%) 23 (57%) 48 (52%) 1061 (59%) 17 (55%)
Original ADNI cohort .005
  ADNI-1 819 (36%) 19 (22%) 14 (30%) 38 (33%) 740 (37%) 8 (23%)
  ADNI-GO 131 (6%) 8 (9%) 1 (2%) 4 (4%) 113 (6%) 5 (14%)
  ADNI-2 790 (35%) 31 (35%) 14 (30%) 34 (30%) 696 (35%) 15 (43%)
  ADNI-3 546 (24%) 30 (34%) 17 (37%) 38 (33%) 454 (23%) 7 (20%)
Amyloid
  Abeta+ 372 (21%) 24 (34%) 12 (38%) 21 (25%) 312 (20%) 3 (11%) .002
  Abeta− 1425 (79%) 47 (66%) 20 (62%) 64 (75%) 1270 (80%) 24 (89%)

Note.

*

Mean (standard deviation) for continuous variables. N is the number of non-missing values.

P-values are derived from tests excluding the Others ethnocultural level.

Tests used:

Wilcoxon test

Pearson test